China Digital Pathology Market Size & Outlook, 2025-2033
The digital pathology market in China is expected to reach a projected revenue of US$ 135.6 million by 2033. A compound annual growth rate of 10.6% is expected of China digital pathology market from 2025 to 2033.
The China digital pathology market generated a revenue of USD 54.4 million in 2024 and is expected to reach USD 135.6 million by 2033.
The China market is expected to grow at a CAGR of 10.6% from 2025 to 2033.
In terms of segment, software was the largest revenue generating product in 2024.
Software is the most lucrative product segment registering the fastest growth during the forecast period.
Digital pathology market data book summary
Market revenue in 2024
USD 54.4 million
Market revenue in 2033
USD 135.6 million
Growth rate
10.6% (CAGR from 2025 to 2033)
Largest segment
Software
Fastest growing segment
Software
Historical data
2021 - 2023
Base year
2024
Forecast period
2025 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Software, Device, Storage Systems
Key market players worldwide
Danaher Corp, Hamamatsu Photonics KK, Koninklijke Philips NV, Olympus Corp, Roche Holding AG ADR, McCormick & Co Inc Registered Shs Non Vtg, Inspire Medical Systems Inc, PHC Holdings Corp, Huron Consulting Group Inc, CellaVision AB Bearer Shs, IBEX Ltd, Morphic Holding Inc, Nuvation Bio Inc Ordinary Shares - Class A
Other key industry trends
In terms of revenue, China accounted for 3.9% of the global digital pathology market in 2024.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Asia Pacific, Japan digital pathology market is projected to lead the regional market in terms of revenue in 2033.
India is the fastest growing regional market in Asia Pacific and is projected to reach USD 113.5 million by 2033.
The digital pathology market in China is anticipated to grow rapidly in coming years. Key players operating in the market are focusing to capitalize on the opportunities owing to growing patient pool and unmet medical needs in the country.
Moreover, strategic alliances to develop novel solutions are expected to further boost the market growth. For instance, in October 2019, Motic Easy Scan and Digital Pathology Company partnered with the British Columbia Cancer Agency for 20 years to offer telepathology consultation and automated cervical cancer screenings in China.
In August 2013, MEDITE, Inc., a manufacturer of laboratory equipment and supplies, entered into a strategic alliance with UNIC Technologies, a China-based manufacturer of digital and tele pathology solutions. As per the agreement, MEDITE would deliver advanced pathology platforms in China.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Digital Pathology Market Outlook will help companies and investors design strategic landscapes.
Software was the largest segment with a revenue share of 48.35% in 2024.
Horizon Databook has segmented the China digital pathology market based on software, device, storage systems covering the revenue growth of each sub-segment from 2021 to 2033.
The digital pathology market in China is anticipated to grow rapidly in coming years. Key players operating in the market are focusing to capitalize on the opportunities owing to growing patient pool and unmet medical needs in the country.
Moreover, strategic alliances to develop novel solutions are expected to further boost the market growth. For instance, in October 2019, Motic Easy Scan and Digital Pathology Company partnered with the British Columbia Cancer Agency for 20 years to offer telepathology consultation and automated cervical cancer screenings in China.
In August 2013, MEDITE, Inc., a manufacturer of laboratory equipment and supplies, entered into a strategic alliance with UNIC Technologies, a China-based manufacturer of digital and tele pathology solutions. As per the agreement, MEDITE would deliver advanced pathology platforms in China.
China Digital Pathology Market Product Outlook (Revenue, USD Million , 2021-2033)
Software
Device
Storage Systems
China Digital Pathology Market Application Outlook (Revenue, USD Million , 2021-2033)
Drug Discovery & Development
Academic Research
Disease Diagnostics
China Digital Pathology Market End-Use Outlook (Revenue, USD Million , 2021-2033)
Hospitals
Biotech & Pharmaceutical Companies
Diagnostic Labs
Academic & Research Institutes
China Digital Pathology Market Type Outlook (Revenue, USD Million , 2021-2033)
Human Pathology
Veterinary Pathology
Reasons to subscribe to Digital Pathology Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Digital Pathology Market Outlook databook
Our clientele includes a mix of Digital Pathology Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China Digital Pathology Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into China Digital Pathology Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.